LeMaitre Vascular Balance Sheet Health
Financial Health criteria checks 6/6
LeMaitre Vascular has a total shareholder equity of $308.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $354.0M and $45.5M respectively. LeMaitre Vascular's EBIT is $40.9M making its interest coverage ratio -11.7. It has cash and short-term investments of $108.3M.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | -11.7x |
Cash | US$108.29m |
Equity | US$308.50m |
Total liabilities | US$45.45m |
Total assets | US$353.96m |
Recent financial health updates
No updates
Recent updates
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$85.0 Based On Its Intrinsic Value?
Jul 12Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Jun 18Return Trends At LeMaitre Vascular (NASDAQ:LMAT) Aren't Appealing
Jun 05LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear
May 02Is Now The Time To Put LeMaitre Vascular (NASDAQ:LMAT) On Your Watchlist?
Apr 04Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Feb 29What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?
Jan 19Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Paint A Concerning Picture
Oct 27Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Oct 11Does LeMaitre Vascular (NASDAQ:LMAT) Deserve A Spot On Your Watchlist?
Aug 30The Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Don't Inspire Confidence
Jul 06Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$62.3 Based On Its Intrinsic Value?
May 20Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Mar 12Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Oct 23Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Oct 05LeMaitre Vascular (NASDAQ:LMAT) Could Be Struggling To Allocate Capital
Sep 13LeMaitre Vascular: Reiterate Buy Thesis Following Strong Q2 Numbers
Sep 08LeMaitre Vascular goes ex dividend tomorrow
Aug 23LeMaitre Vascular: 16% Return Objective From Idiosyncratic Risk Premia
Jun 24What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?
Jun 15Are Investors Undervaluing LeMaitre Vascular, Inc. (NASDAQ:LMAT) By 40%?
May 06Financial Position Analysis
Short Term Liabilities: LMAT's short term assets ($203.0M) exceed its short term liabilities ($26.8M).
Long Term Liabilities: LMAT's short term assets ($203.0M) exceed its long term liabilities ($18.6M).
Debt to Equity History and Analysis
Debt Level: LMAT is debt free.
Reducing Debt: LMAT had no debt 5 years ago.
Debt Coverage: LMAT has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: LMAT has no debt, therefore coverage of interest payments is not a concern.